Profile | GDS2987 / GI_20336195-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | 18.9 | 45 |
GSM215282 | HMVEC_atorvastatin_rep3 | 33.7 | 59 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 8.9 | 18 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 17.3 | 51 |
GSM215295 | HMVEC_SLx2119_rep2 | 10.3 | 21 |
GSM215296 | HMVEC_SLx2119_rep3 | 23.6 | 37 |
GSM215297 | PASMC_vehicle_rep1 | 25.1 | 37 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 29.5 | 46 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | 71.6 | 68 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 31.4 | 47 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 20.9 | 34 |
GSM215327 | PASMC_SLx2119_rep1 | 4.6 | 8 |
GSM215328 | PASMC_SLx2119_rep2 | 26.7 | 44 |
GSM215329 | PASMC_SLx2119_rep3 | 3.8 | 8 |
GSM215330 | Fibroblasts_vehicle_rep1 | 15.5 | 35 |
GSM215331 | Fibroblasts_vehicle_rep2 | 6.8 | 20 |
GSM215332 | Fibroblasts_vehicle_rep3 | 5.4 | 19 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 1.2 | 3 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 10.4 | 29 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 1.9 | 5 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 3.8 | 13 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 4.4 | 15 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 6.6 | 19 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 21.5 | 52 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 32.3 | 62 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 1.1 | 3 |